Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
Clinical Trial
NCT06430385Last updated: 12/5/2025
IONS
Ionis Pharmaceuticals, Inc.
